Healthcare stakeholders are looking to third parties to help evaluate the value of new medical products. But defining value is complicated. Read about efforts to assess product value, including Avalere’s initiative to develop a value framework that incorporates the patient perspective.
In a recent webinar, experts from Avalere and the National Patient Advocate Foundation discussed the value of shared decision-making (SDM) and preparing patients and families for navigating their care journeys.
Experts from Avalere and the National Patient Advocate Foundation (NPAF) discussed the value of shared decision-making (SDM) and preparing patients and families for navigating their care journeys.
Avalere published an abstract in the online Journal of National Comprehensive Cancer Network (JNCCN).
Avalere’s “Preparation for Shared Decision-Making” (PFSDM) tool aims to help patients with advanced breast cancer (ABC) feel prepared to communicate with their clinicians and engage in decision making aligned with their preferences. The validation study confirms the acceptability and usability of the tool for women with ABC.
Avalere used a human-centered design approach to adapt a patient-centered tool to help patients prepare to make treatment decisions with their clinicians.
To achieve the goals of value-based care, the patient voice must be incorporated into clinical decision-making by embedding shared decision-making (SDM) as a routine part of clinical practice.
Avalere published a white paper outlining global recommendations to increase the patient centricity of value assessment framework methodology and application.
In 2018, Avalere partnered with CancerCare and Gabrielle Rocque, an oncologist at the University of Alabama Birmingham School of Medicine, to develop the Preparation for Shared Decision Making (PFSDM) tool.
Despite recognition that providers should implement shared decision making (SDM) as standard practice, integration of SDM into regular care delivery remains elusive.
Transformative medicines, like gene and cell therapies, are beginning to be approved in the US, and more are expected to come.
Avalere used a human-centered design approach structured around patient preferences to help guide advanced breast cancer patients.
Today, Avalere published a technical appendix to the PPVF Version 1.0 methodology report, outlining a quantitative method for incorporating patient preferences into value assessments and healthcare decision making.
Evidence suggests that shared decision-making can play a role in advancing a value-based care delivery system.
Avalere’s Teigland was selected by the National Quality Forum to participate in the Disparities Standing Committee.
Tune in as our experts discuss the key differences making the the Patient-Perspective Value Framework 1.0 (PPVF) unique compared to value frameworks currently in the market.
Blog post features key learnings from the Patient-Perspective Value Framework.
Today, Avalere and FasterCures published Version 1.0 of the Patient-Perspective Value Framework (PPVF).
This week, FasterCures provided Avalere with a second round of seed funding to test, refine and validate the PPVF.
Today, the Institute for Clinical and Economic Review (ICER) released an updated version of its Value Assessment Framework.
Avalere and the Robert Wood Johnson Foundation Launch Eight Grants to Improve Cost-of-Care Conversations Between Patients and Clinicians.